...
首页> 外文期刊>Spectrochimica Acta, Part B. Atomic Spectroscopy >Rhodium as permanent modifier for atomization of lead from biological fluids usign tungsten filament electrothermal atomic absorption spectrometry
【24h】

Rhodium as permanent modifier for atomization of lead from biological fluids usign tungsten filament electrothermal atomic absorption spectrometry

机译:铑作为永久性改性剂,可用于钨丝电热原子吸收光谱法中的生物液中铅的雾化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Rhodium (Rh) was investigated as a permanent modifier for the atomization of Pb from biological fluids in W-filament atomic absorption spectrometry (AAS). Heating the W-filament with a Rh solution provided a protective coating for subsequent determinations of Pb in blood and urine matrices. The W-filament AAS instrumentation used coating for subsequent determinations of Pb in blood and urine matrices. The W-filament AAS instrumentation used was based on a prototype design that utilized self-reversal background correction scheme and peak area measurements. We found that Rh not only stabilized Pb during the pryolysis step, but also facilitated the removal of carbonaceous residues during the cleaning step, requiring much less power than with phosphate modifier. Thus, the filament lifetime was greatly extended to over 300 firings. Periodic reconditioning with Rh was necessary every 30 firings or so. Conditioning the filament with Rh also permitted direct calibration using simple aqueous Pb standards. The method detection limit for blood Pd was approximately 1.5 #mu#g dl~(-1), similar to that reported previously. Potential interferences from concomitants such as N,a K, Ca and Mg were evaluated. Accuracy was verified using lead reference materials from the National Institute of Standards and Technology and the New York State Department of Health. Blood lead results below 40 #mu#g dl~(-1) were within +-1 #mu#g dl~(-1) of certified values, and within +=10% above 40 #mu#g dl~(-1); within run precision was +- 10% or better. Additional validation was reported using proficiency test materials and human blood specimens. All blood lead results were within the acceptable limits established by regulatory authorities in the US. When measuring Pb in urine, sensitivity was reduced and matrix-matched calibration became necessary. The method of detection limit was 27 #mu#g l~(-1) for urine Pb. Urine lead results were also validated using an acceptable range comparable to that established for blood lead by US regulatory agencies.
机译:在W丝原子吸收光谱法(AAS)中,研究了铑(Rh)作为从生物流体中雾化铅的永久性改性剂。用Rh溶液加热W细丝为随后测定血液和尿液中的Pb提供了保护层。 W丝AAS仪器使用涂层来随后测定血液和尿液基质中的Pb。所使用的W丝AAS仪器基于原型设计,该原型利用了自我反转背景校正方案和峰面积测量。我们发现,Rh不仅在高温分解步骤中稳定了Pb,而且在清洁步骤中也促进了碳质残留物的去除,所需功率比磷酸盐改性剂低得多。因此,灯丝的寿命大大延长到超过300次烧成。每30次点火大约需要定期用Rh进行修复。用Rh调节灯丝还可以使用简单的含水Pb标准品直接校准。血液中Pd的方法检出限约为1.5#mu#g dl〜(-1),与先前报道的相似。评估了来自伴随物如N,a K,Ca和Mg的潜在干扰。使用美国国家标准技术研究所和纽约州卫生部的主要参考材料验证了准确性。低于40#mu#g dl〜(-1)的血铅结果在认证值的+ -1#mu#g dl〜(-1)范围内,而在40#mu#g dl〜(-1)的基础上+ = 10%以内。 1);运转精度在±10%或更高。据报道,使用能力验证材料和人类血液样本还进行了进一步的验证。所有血铅结果均在美国监管机构规定的可接受范围内。当测量尿液中的铅时,灵敏度降低,需要进行基质匹配的校准。尿铅的检出限为27#mu#g l〜(-1)。还使用与美国监管机构为血铅确定的可接受范围相当的可接受范围来验证尿铅结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号